Development and Evaluation of a Community-Based Pharmacist-Led Medication Adherence Program

Thesis Abstract

Non-adherence to prescribed medication regimens remains a significant barrier to achieving optimal health outcomes in chronic disease management, particularly within community settings where access to timely health interventions is limited. Despite the recognized role of pharmacists as accessible healthcare providers, the integration of pharmacist-led interventions to improve medication adherence has yet to be fully evaluated within community-based contexts. This study aims to develop, implement, and rigorously evaluate a community-centered pharmacist-led medication adherence program designed to enhance adherence rates among patients with chronic conditions such as hypertension and diabetes mellitus. The specific objectives are to (1) identify barriers to medication adherence within the target population, (2) design and pilot-test a structured pharmacist-led adherence intervention tailored to community needs, (3) assess the effectiveness of the intervention in improving medication adherence, and (4) evaluate patient and pharmacist satisfaction with the program. Employing a mixed-methods research design, the study integrates quantitative and qualitative approaches to obtain comprehensive insights. The quantitative component utilizes a quasi-experimental pre-post intervention design with a control group, involving a sample of 300 patients recruited from three community pharmacies. Participants are randomly assigned to either the intervention or control group, with the intervention group receiving monthly medication counseling, adherence reminders via SMS, and personalized medication management support over six months. Data on medication adherence are collected via the Morisky Medication Adherence Scale (MMAS-8), pharmacy refill records, and biometric indicators such as blood pressure and glycemic control. Qualitative data are gathered through semi-structured interviews with 30 patients and 10 pharmacists to explore perceptions, experiences, and factors influencing adherence behaviors. Data analysis involves descriptive statistics, paired t-tests, and multivariate regression analysis to determine the intervention's effectiveness in improving adherence and clinical outcomes. Thematic analysis is applied to qualitative data to identify recurring themes related to program acceptability and perceived barriers. The theoretical frameworks guiding the study are the Health Belief Model and the Theory of Planned Behavior, which inform the design of the intervention and interpretation of findings. It is anticipated that the pharmacist-led program will significantly improve medication adherence rates—expected to increase by at least 20%—and concurrently enhance clinical indicators such as blood pressure and fasting blood glucose levels. The findings are expected to demonstrate that community-based pharmacist interventions are both feasible and effective, leading to higher patient satisfaction and greater engagement in disease management. The study will contribute to existing knowledge by providing evidence for the scalability and sustainability of pharmacist-led adherence programs in community settings, filling a gap identified in current literature regarding practical implementation and outcome evaluation in real-world contexts. The main conclusion emphasizes that structured pharmacist-led interventions can substantially improve medication adherence among chronic disease patients in community environments. Recommendations include integrating such programs into standard community pharmacy practice, policy formulation for expanded pharmacist roles, and routine training on adherence strategies. Further research is suggested to evaluate long-term impacts, cost-effectiveness, and adaptations in diverse geographical and socio-economic contexts, thereby advancing the operational frameworks for community pharmacist-led healthcare initiatives aimed at optimizing medication adherence and overall health outcomes.